PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ursodeoxycholic acid - Gallstones
PAD Profile : Ursodeoxycholic acid - Gallstones Important
Brand Names Include :
Destolit, Urdox, Ursofalk, Ursogal, Cholerso
Important Information :
Transfer of care to primary care may be appropriate after initiation by the specialist.
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
19 November 2008
Surrey Medicines Commissioners Group
Local acute Trusts requested that ursodeoxycholic acid, used in the treatment of gall stones, is changed from Amber* to green. It was agreed that it should remain Amber* as initiation would still need to be carried out by the hospital
Prescribe generically.
Note - the branded product Ursofalk 250mg capsules were considered BLACK at the May 2017 PCN
Associated BNF Codes
01. Gastro-Intestinal System
01.09.01. Drugs affecting biliary composition and flow